Old Web
English
Sign In
Acemap
>
Paper
>
Biomarkers Afp In Combination With Afp-L3 And Dcp Predicts Tumor Progression In Treatment Naïve Hcc Patients
Biomarkers Afp In Combination With Afp-L3 And Dcp Predicts Tumor Progression In Treatment Naïve Hcc Patients
2020
K. Nuñez
T. Sandow
Paul Thevenot
A. Cohen
Keywords:
Surgery
therapy naive
AFP-L3
Internal medicine
Tumor progression
Biomarker (medicine)
Oncology
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]